Pharma industry insights and updates

With in-person events back on track, it’s time for pharma marketplaces to reimagine themselves

With the events circuit in full swing after two years of intermittent lockdowns, many pharma manufacturers and buyers can finally meet in person, discuss business opportunities and refresh their knowledge of the ever-changing field. Having recently visited CPHI in Frankfurt myself, I can attest to all these benefits that the industry missed during the pandemic. But what does this “return to normal” mean for B2B marketplaces that have grown in the last few years?

Pipelinepharma adds biosimilars, medical devices and nutraceuticals to its platform

Pipelinepharma, a B2B marketplace with 85 000+ finished dose formulation products, announces adding 3 new categories in addition to generic drugs, vastly expanding its offering.

Tips for submitting an actionable RFQ on the marketplace

At Pipelinepharma, we seek to make all interactions via the B2B marketplace as simple as possible. This includes registration, search, and communication. The same principle of simplicity applies when a pharma buyer decides to submit a request for a quotation (RFQ).

Major drugs going off-patent in 2020-2026 bring opportunities to both manufacturers and buyers

Generics manufacturers have been waiting for something of the same scale as the 2011-2016 Patent Cliff, when the expiration of multiple blockbuster patents coincided, unlocking hundreds of billions in value. Watching drugs going off-patent in 2020-2026, it looks like we are entering a period of increased opportunities and potential.

How can generics manufacturers unlock more business opportunities

The market for generic drugs around the world is only going to grow. At the moment, we see varying market penetration rates across Europe and other developed markets, but due to market trends, in a decade or so, generic penetration across developed markets may well amount to around 80-90%.

Pipelinepharma records quadruple growth over a single year

Marketplaces are a standard staple for many B2B industries. By connecting buyers and sellers in the digital realm, marketplaces significantly reduce dealmaking time and effort. Europe alone lists more than 1700 online marketplaces, with more than 30% aimed at business-to-business transactions.

Urgent call for medicines in Ukraine

At Pipelinepharma we stand united with the people of Ukraine. We are calling upon our contacts to support the urgent needs of medicines in Ukraine. With your help, together we can save lives and ensure the continuity of healthcare services for the Ukrainian people.

Cooperative buying to help launch new medicines in small markets

Large manufacturer minimum order quantities put specialist medicines out of reach of buyers in smaller markets. By grouping pharmaceutical orders from different buyers into a single collective bulk order, Pipelinepharma will help buyers to reach the minimum order quota. The initiative further builds upon Pipelinepharma’s mission to provide better access to medicines for patients all around the world.

Pharmaceutical companies shift to near-shore medicines sourcing

With global supply chains under stress due to the COVID-19 pandemic, European pharmaceutical companies and distributors are increasingly looking for alternative supply channels inside the EU block. The number of requests for commercial proposals from European distributors when drug manufacturers are also based in Europe has increased by 69% in 2021, compared to the previous year.